WXIFF: Successful Reexamination of Patent for Tetrodotoxin (Nasdaq)
Posted in Patents on April 30th, 2008WXIFF: Successful Reexamination of Patent for Tetrodotoxin (Nasdaq)
WEX Pharmaceuticals Inc. (WXIFF) announced that the U.S. Patent and Trademark Office has issued a Reexamination Certificate for United States Patent No. 6,407,088, titled “Method of Analgesia”. This patent relates to the use of tetrodotoxin (TTX) for producing analgesia in humans.






